Author Topic: Mayzent (siponimod, BAF312) for active SPMS, RRMS  (Read 525 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8588
  • MS diagnosed 1980
  • Location: Pacific Northwest
Studies are busily being done on the cost effectiveness of siponimod, to be known as Mayzent, according to this blog post from Multiple Sclerosis News Today (March 20, 2019)--"SPMS treatment with Mayzent could be cost-effective, ICER report says":


https://multiplesclerosisnewstoday.com/2019/03/20/icer-report-spms-treatment-mayzent-could-be-cost-effective/




MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
74 Views
Last post April 01, 2019, 04:00:21 pm
by agate
0 Replies
39 Views
Last post May 06, 2019, 09:17:34 pm
by agate
1 Replies
66 Views
Last post October 02, 2019, 06:23:25 am
by agate
0 Replies
38 Views
Last post October 31, 2019, 08:49:09 am
by agate
0 Replies
18 Views
Last post January 29, 2020, 09:35:32 pm
by agate